FundComb
Estimated Control Closed Transaction verified blister careConsumerconsumer self careconsumer self care / nonprescription healthcarenonprescription healthcareOTC self care

Héra / HRA Pharma acquired by Perrigo

Perrigo acquired Héra / HRA Pharma, an otc self care / consumer healthcare brand.

Transaction summary

Target
Héra / HRA Pharma
Acquirer
Perrigo
Announced
2021-09-08
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-18
Latest update
2026-07-13

Value and multiples

100% enterprise value

USD 2.1B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

4.45x

Period: Forward 2023

Basis: Derived from source data

EV / EBITDA

-

EBITDA basis not stated

Basis: Derived from source data

Basis

  • Revenue: €400 million, reported as roughly $472 million by Fierce Pharma. EV/revenue: $2,100 million / $472 million = 4.45x. Price source: https://news.google.com/rss/articles/CBMitAFBVV95cUxONG1tcF9DWjVKY0xtdWd6NXBhV2JwRGNJSUV5dTNJbGVMalYzVGEwTnprYWRXaHUxSi1EM2hUbGs3WlRiMmVSWmdmejRCUkJjMFQ0Ymo0dXRCQVBWMFJvSDZYVjQ2Vk9FXzM1aEo3WFBYSzhucmRvZkloY0pWRExGTTBNSHpyODRwMGZqNkJGQmVQT2dzMkxGaDNCREpqYy1LMHg1VU1tZTh5T0x3WUl6bXlmR1U?oc=5 ; revenue source: https://www.fiercepharma.com/pharma/perrigo-dishes-out-2-1b-for-hra-pharma-a-crowning-achievement-quest-to-become-self-care

Other reviewed estimates

Earlier estimates and their sources.

other reviewed estimate
EBITDA USD 117m | EV / EBITDA 18x
EV/Sales 4.8x and EBITDA multiple 18.0x are from pasted spreadsheet context, not verified by supplied public web evidence.
EV / revenue 4.8x | EV / EBITDA 18x

Source summary

Perrigo to buy HRA Pharma in $2.1 bln deal to expand self-care portfolio - Reuters

Confirmed
Open via Google News

Perrigo to Buy Héra for $2.1 Billion, Furthering Nonprescription Focus - WSJ

Confirmed
Open via Google News

Perrigo dishes out $2.1B for HRA Pharma, a big step on its quest to become a self-care company

Estimated

Article states Perrigo agreed to acquire HRA Pharma for $2.1 billion and that Perrigo expected the transaction to deliver about €400 million, roughly $472 million, in sales by 2023.

Open source

Continue your research

Related transaction comps

Explore more comps →
Same buyer / investor

Ranir Global Holdings LLC acquired by Perrigo

2019-05-09 · Estimated

View transaction → Skin Care

Saltair acquired by TSG Consumer

2026-07-30 · Confirmed

View transaction → Skin Care

rhode acquired by e.l.f. Beauty

2025-05-28 · Confirmed

View transaction → Skin Care

Minimalist acquired by Hindustan Unilever

2025-01-22 · Confirmed

View transaction →